A Case Report of Turner Syndrome and Literature Review

Pingping Chen

doi:10.54097/ijbls.v3i3.11

Authors

Pingping Chen

DOI:

https://doi.org/10.54097/ijbls.v3i3.11

Keywords:

Turner Syndrome, Clinical Features, Sex Hormones, Lipids

Abstract

Turner syndrome (TS), also known as congenital dysplasia of ovary syndrome, is the most common female chromosomal abnormality, and the incidence of live birth girls is 1/2 000 ~ 1/2 500. The main clinical manifestations of Turner syndrome are spinal trunk abnormality, growth retardation, sexual dysplasia and special physical characteristics, and abnormal sex hormone, abnormal growth hormone, dyslipidemia, etc. This article summarized and analyzed the clinical characteristics and test results of a child with Turner syndrome, combined with literature review, in order to improve the understanding of Turner syndrome and clinical diagnosis and treatment.

Downloads

Download data is not yet available.

References

Yan Chun, Wang Muti. Pediatric Endocrinology [M]. Beijing: People's Medical Publishing House, 2006:348-355.

Yesilkaya E, Bereket A, Darendeliler F, Bas F, et al. Turner syndrome and associated problems in Turkish children: a multicenter study [J]. J Clin Res Pediatr Endocrinol. 2015 Mar; 7 (1): 27-36.

Ross JL, Feuillan P, Long LM, et al. Lipid abnor⁃malities in Turner syndrome [J]. J Pediatr, 1995,126 (2): 242-245.

Huang Siqi, Chen Hongshan, Du Minlian et al. Analysis of dyslipidemia and related factors in Chinese children and adolescents with Turner syndrome [J]. Journal of Sun Yat-sen University (Med Edition),2018,39(03):420-426. (in Chinese)

Yan Kunli. Analysis of chromosome karyotype distribution and lipid level in children with Turner syndrome [J/OL]. Zhejiang University, 2015: 1-17. Yan KL. The study on the chromosomal karyotypes distribbution and lipid concentrations in children with Turner syndrome [J/OL]. Zhejiang Univ, 2015:1-17.

Qin Shuang, Luo Songping, Ju Rui. China expert consensus Turner syndrome (2022 edition) [J]. Chinese journal of practical gynecology and obstetrics, 2022, 38 (4): 424-433. The DOI: 10.19538 / j. f k2022040111.

Zheng X M, Liu G L.45, abnormal sex differentiation induced by XO [J]. Chinese Journal of Practical Internal Medicine, 2004 (11):649-651. (in Chinese)

LI P, CHENG F, XIU L. Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis[J]. Endocr Connect, 2018, 7(4): 573-583.

CARPINI S, CARVALHO A B, de LEMOS-MARINI S H V, et al. FSH may be a useful tool to allow early diagnosis of Turner syndrome[J]. BMC Endocr Disord, 2018, 18: 1186-1194.

SHANKAR R K, BACKELJAUW P F. Current best practice in the management of Turner syndrome[J]. Ther Adv Endocrinol Metab, 2018, 9(1): 33-40.